Cargando…
A human fetal liver-derived infant MLL-AF4 acute lymphoblastic leukemia model reveals a distinct fetal gene expression program
Although 90% of children with acute lymphoblastic leukemia (ALL) are now cured, the prognosis for infant-ALL remains dismal. Infant-ALL is usually caused by a single genetic hit that arises in utero: an MLL/KMT2A gene rearrangement (MLL-r). This is sufficient to induce a uniquely aggressive and trea...
Autores principales: | Rice, Siobhan, Jackson, Thomas, Crump, Nicholas T., Fordham, Nicholas, Elliott, Natalina, O’Byrne, Sorcha, Fanego, Maria del Mar Lara, Addy, Dilys, Crabb, Trisevgeni, Dryden, Carryl, Inglott, Sarah, Ladon, Dariusz, Wright, Gary, Bartram, Jack, Ancliff, Philip, Mead, Adam J., Halsey, Christina, Roberts, Irene, Milne, Thomas A., Roy, Anindita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616957/ https://www.ncbi.nlm.nih.gov/pubmed/34824279 http://dx.doi.org/10.1038/s41467-021-27270-z |
Ejemplares similares
-
H3K79me2/3 controls enhancer–promoter interactions and activation of the pan-cancer stem cell marker PROM1/CD133 in MLL-AF4 leukemia cells
por: Godfrey, Laura, et al.
Publicado: (2020) -
P332: LIN28B: AN IMPORTANT ONCO-FETAL GENE IN INFANT ACUTE LYMPHOBLASTIC LEUKAEMIA
por: Ling, Rebecca, et al.
Publicado: (2023) -
Defining the fetal origin of MLL-AF4 infant leukemia highlights specific fatty acid requirements
por: Symeonidou, Vasiliki, et al.
Publicado: (2021) -
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia
por: Kerry, Jon, et al.
Publicado: (2017) -
MLL-AF4 cooperates with PAF1 and FACT to drive high-density enhancer interactions in leukemia
por: Crump, Nicholas T., et al.
Publicado: (2023)